Compare Merck & Co., Inc. (MRK) vs Pinterest Inc (PINS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Merck & Co., Inc. vs Pinterest Inc — how do they compare? Merck & Co., Inc. trades at $133.82 (market cap $321.77B), while Pinterest Inc trades at $22.89 (market cap $13.45B). The key difference: Merck & Co., Inc. is far larger — about 23.9× Pinterest Inc's market cap, and Merck & Co., Inc. pays a 2.61% dividend while Pinterest Inc pays none. Which is the better fit depends on your goals.
| MRK | PINS | |
|---|---|---|
Market Cap | $321.77B | $13.45B |
Sector | Health | Media |
52-Week High | $131.84 | $37.95 |
52-Week Low | $77.60 | $15.42 |
Enterprise Value | $368.53B | $13.37B |
Dividend Yield | 2.61% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MRK trades at $133.6, up 2.06% today, near its 52-week high. The stock shows a bullish technical trend with strong moving average support. Recent earnings have consistently beaten estimates, with Q3 2026 expected at $2.27 EPS. The company's acquisition of Terns Pharmaceuticals aims to bolster its oncology pipeline, while revenue growth remains steady at $65.01B in 2025.
MRK presents a positive outlook with a consensus price target of $140.36, indicating potential upside. Strong institutional buying and a 67.57% buy rating from analysts support bullish sentiment. Risks include rising debt-to-asset ratios and competitive pressures in the pharma sector. The dividend yield of $0.85 per half-year adds income appeal for long-term investors.
Pinterest (PINS) trades at $22.93, down 5.91% over 24 hours, reflecting market disappointment despite strong Q2 2026 earnings beats. Revenue growth remains robust at 18% year-over-year, driven by AI-powered ads and record user growth to 640 million monthly active users. Technical indicators show a bullish moving average signal but neutral oscillators, with key support at $23. Recent news highlights a federal securities lawsuit investigation and CFO stock sales, adding volatility.
The outlook is mixed: solid fundamentals and a $28.69 analyst price target suggest upside, but competitive ad markets and lukewarm Q3 guidance pose risks. Investor sentiment is cautious despite bullish analyst consensus, with the stock's high P/E ratio of 69.85 requiring sustained growth to justify valuations. Key opportunities lie in international expansion and AI monetization, while legal and competitive pressures are headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Merck & Co., Inc.
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the firm's sales are generated in the United States.
Read more on MRK →About Pinterest Inc
Pinterest is an online product and idea discovery platform that helps users gather ideas on everything from recipes to cook to destinations to travel to. Founded in 2010, the platform consists of a largely female audience, at roughly two thirds of its more than 365 million monthly active users. The company generates revenue by selling digital ads and is now rolling out more in-platform e-commerce features.
Read more on PINS →
